Vascular biology of eicosanoids and atherogenesis (Q28259045)

Expert Review of Cardiovascular Therapy

Europe PubMed Central

title

Vascular biology of eicosanoids and atherogenesis (English)

0 references

author name string

Domenico Praticò

series ordinal

1

0 references

Jean-Michel Dogné

series ordinal

2

0 references

language of work or name

English

0 references

publication date

September 2009

0 references

published in

0 references

volume

7

0 references

issue

9

0 references

page(s)

1079-89

0 references

cites work

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).

21 January 2018

1 reference

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia

21 January 2018

1 reference

Fibrinolysis and cardiovascular risk factors: association with fibrinogen, lipids, and monocyte count

21 January 2018

1 reference

Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease

21 January 2018

1 reference

Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study

21 January 2018

1 reference

Inflammation and atherosclerosis

21 January 2018

1 reference

Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis

21 January 2018

1 reference

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

21 January 2018

1 reference

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system

21 January 2018

1 reference

COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells.

21 January 2018

1 reference

Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention

21 January 2018

1 reference

Cloning of cyclooxygenase-1b (putative COX-3) in mouse.

21 January 2018

1 reference

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

21 January 2018

1 reference

Expression of cyclooxygenase-2 in the macula densa of human kidney in hypertension, congestive heart failure, and diabetic nephropathy

21 January 2018

1 reference

New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators

21 January 2018

1 reference

Peroxynitrite as regulator of vascular prostanoid synthesis

21 January 2018

1 reference

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

21 January 2018

1 reference

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine

21 January 2018

1 reference

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan

21 January 2018

1 reference

Activation of thromboxane receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression through JNK signaling.

21 January 2018

1 reference

The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

21 January 2018

1 reference

Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis

21 January 2018

1 reference

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study

21 January 2018

1 reference

S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits

21 January 2018

1 reference

Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice

21 January 2018

1 reference

Coxibs and cardiovascular side-effects: from light to shadow.

21 January 2018

1 reference

Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function

21 January 2018

1 reference

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

21 January 2018

1 reference

Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension

21 January 2018

1 reference

Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.

21 January 2018

1 reference

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

21 January 2018

1 reference

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

21 January 2018

1 reference

Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice

21 January 2018

1 reference

Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis

21 January 2018

1 reference

No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice

21 January 2018

1 reference

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

21 January 2018

1 reference

The isoprostanes in biology and medicine

21 January 2018

1 reference

Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

21 January 2018

1 reference

Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

21 January 2018

1 reference

Oxidized phospholipids and isoprostanes in atherosclerosis

21 January 2018

1 reference

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

21 January 2018

1 reference

Lipid peroxidation in mouse models of atherosclerosis

21 January 2018

1 reference

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

21 January 2018

1 reference

The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis

21 January 2018

1 reference

Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions

21 January 2018

1 reference

Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E

21 January 2018

1 reference

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study

21 January 2018

1 reference

F2-isoprostanes are not just markers of oxidative stress

21 January 2018

1 reference

Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice

21 January 2018

1 reference

Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin

21 January 2018

1 reference

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

21 January 2018

1 reference

Additive anti-atherogenic effect of thromboxane receptor antagonism with 12/15lipoxygenase gene disruption in apolipoprotein E-deficient mice

21 January 2018

1 reference

C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population

21 January 2018

1 reference

Mediation of augmented monocyte adhesiveness by thromboxane

21 January 2018

1 reference